Cupid Limited Reconstitutes Audit Committee with Three Independent Directors
Cupid Limited reconstituted its Audit Committee on March 30, 2026, appointing Mrs. Rajni Mishra as Chairperson along with two other independent directors as members. The Board resolution was passed by circulation and communicated to stock exchanges under SEBI regulations. This governance update ensures continued compliance with listing requirements for the healthcare products manufacturer.

*this image is generated using AI for illustrative purposes only.
Cupid Limited has announced the reconstitution of its Audit Committee through a Board resolution passed by circulation on March 30, 2026. The healthcare products manufacturer communicated this corporate governance update to both BSE and NSE under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Committee Composition
The reconstituted Audit Committee comprises three members, all holding Non-Executive & Independent Director positions. The new structure ensures compliance with corporate governance norms for listed companies.
| Position | Name | Category |
|---|---|---|
| Chairperson | Mrs. Rajni Mishra | Non-Executive & Independent Director |
| Member | Mr. Thallapaka Venkateswara Rao | Non-Executive & Independent Director |
| Member | Mr. Bontha Prasada Rao | Non-Executive & Independent Director |
Regulatory Compliance
The company filed the mandatory disclosure with stock exchanges to inform stakeholders about the committee changes. Company Secretary and Compliance Officer Saurabh V. Karmase digitally signed the regulatory filing on March 30, 2026.
Company Background
Cupid Limited operates as a manufacturer and exporter of male condoms, female condoms, water-based lubricants, and In Vitro Diagnostics (IVD) kits. The company is headquartered at A-68, M.I.D.C. (Malegaon), Sinnar, Nashik, Maharashtra, and trades on BSE under scrip code 530843 and NSE under scrip code CUPID.
The reconstitution reflects the company's commitment to maintaining robust corporate governance practices through independent oversight of its audit functions.
Historical Stock Returns for Cupid
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.83% | +4.40% | +2.19% | +92.81% | +553.82% | +689.92% |
What strategic initiatives or financial challenges might have prompted Cupid Limited to reconstitute its entire Audit Committee with new independent directors?
How could this governance restructuring impact Cupid's upcoming financial audits and potential regulatory scrutiny in the healthcare products sector?
Will the new Audit Committee composition influence Cupid's expansion plans in the IVD kits segment, given the increased regulatory oversight in diagnostics post-pandemic?

































